Viewing Study NCT05433532


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-04-15 @ 10:01 PM
Study NCT ID: NCT05433532
Status: COMPLETED
Last Update Posted: 2024-04-25
First Post: 2022-06-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Azacitidine,Venetoclax,and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients
Sponsor: The First Affiliated Hospital of Soochow University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: AZA+VEN+TKI
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators